13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0000902664-24-003553
Total Value
$135.3M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 7,000,000 | $43.2M | 31.91% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $41.1M | 30.34% |
| 3 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $13.7M | 10.15% |
| 4 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $10.4M | 7.68% |
| 5 | SILENCE THERAPEUTICS PLC | SLNCF | 299,400 | $6.5M | 4.78% |
| 6 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 110,400 | $5.4M | 4.02% |
| 7 | CURIS INC | CRIS | 421,951 | $4.6M | 3.39% |
| 8 | BRIDGEBIO PHARMA INC | BBIO | 121,200 | $3.7M | 2.77% |
| 9 | TG THERAPEUTICS INC | TGTX | 161,600 | $2.5M | 1.82% |
| 10 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $2.3M | 1.73% |
| 11 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.9M | 1.42% |